Renaissance Energy Investment Co., Ltd.
Renaissance Energy Investment Co., Ltd. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20130241097 | Method for Producing Porous Monolith - A method for producing a monolithic porous body having a trimodal hierarchical porous structure by a sol-gel method is provided. The method includes a sol preparation step of preparing a precursor sol, a gelation step of inducing a sol-gel transition and a phase separation in parallel on the precursor sol in a gelation container housing a template obtained by configuring organic polymer fibers into an aggregation having a three-dimensional spread, to form a gel made of a co-continuous structure of a hydrogel phase and a solvent phase, in the space around the organic polymer fibers, and a removal step of removing the solvent phase and the organic polymer fibers individually or simultaneously from the gel. The organic polymer fibers have a structure in which the cross section perpendicular to the longitudinal direction is contractible while the extension in the longitudinal direction is restricted. Template holes, through-pores and smallpores are formed in voids remaining after the removal of the organic polymer fibers, voids remaining after the removal of the solvent phase, and a skeleton of the hydrogel phase, respectively. | 09-19-2013 |
20130012404 | CULTURE METHOD, EVALUATION METHOD AND STORAGE METHOD FOR CANCER-TISSUE-DERIVED CELL MASS OR AGGREGATED CANCER CELL MASS - It is intended to provide a method for culturing a novel cancer tissue-derived cell mass or a novel aggregated cancer cell mass that can reflect the behavior of cancer cells accurately in vivo. First, a cancer tissue-derived cell mass or an aggregated cancer cell mass is prepared from an individual. The novel cancer tissue-derived cell mass or the novel aggregated cancer cell mass is cultured, and the properties are evaluated using the cultured cell mass. Examples of the evaluation of properties include the evaluation of genes and the evaluation of culture conditions. In addition, the cancer tissue-derived cell mass or the aggregated cancer cell mass can be stored. It is possible to establish an optimal therapeutic method for an individual efficiently by linking the clinical information or the genetic information on the individual to the stored cancer tissue-derived cell mass or the stored aggregated cancer cell mass. | 01-10-2013 |